Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials
To access this article, please choose from the options below
We declare that we have no conflict of interest. This study was supported by grants from Novo Nordisk, Küsnacht, Switzerland, Roche Diagnostics, Rotkreuz, Switzerland, and Glaxo Smith Kline, Münchenbuchsee, Switzerland.
PII: S0002-8703(05)00870-7
doi:10.1016/j.ahj.2005.09.015
© 2006 Published by Elsevier Inc.
